Novo Nordisk
NVO
473 hedge funds and large institutions have $8.79B invested in Novo Nordisk in 2014 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 170 increasing their positions, 164 reducing their positions, and 24 closing their positions.
58% more capital inflows, than outflows
Capital inflows: $916M | Capital outflows: $582M
54% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 24
3% more funds holding
Funds holding: 461 → 473 (+12)
4% more repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 164
0.33% more ownership
Funds ownership: 8.01% → 8.35% (+0.33%)
7% less funds holding in top 10
Funds holding in top 10: 28 → 26 (-2)
68% less call options, than puts
Call options by funds: $3.29M | Put options by funds: $10.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$70.5M |
| 2 |
WCM Investment Management
Laguna Beach,
California
|
+$49.1M |
| 3 |
Renaissance Technologies
New York
|
+$38.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$24.3M |
| 5 |
BlackRock Investment Management
Wilmington,
Delaware
|
+$18.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$359M |
| 2 |
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$56.6M |
| 3 |
Chautauqua Capital Management
Boulder,
Colorado
|
-$20M |
| 4 |
Rockefeller Financial Services
New York
|
-$13M |
| 5 |
Fayez Sarofim & Co
Houston,
Texas
|
-$10.8M |
NVO Hedge Fund Activity: Q2 2014 in Review
473 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q2 2014, worth a combined $8.79B — up 5.4% from $8.34B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new NVO positions and 24 closed out — a net gain of 13 holders — while 170 added to existing stakes and 164 trimmed.
The largest buyer was Arrowstreet Capital, opening a new position worth an estimated $70.5M. The largest seller was Macquarie Group, cutting an estimated $359M.
- 473 institutional investors held Novo Nordisk (NVO) as of Q2 2014, up from 461 in Q1 2014.
- Funds reported $8.79B of Novo Nordisk stock for Q2 2014, up 5.4% quarter-over-quarter.
- 37 funds opened new Novo Nordisk positions in Q2 2014 and 24 closed out, a net change of +13 holders.
- The largest Novo Nordisk buyer in Q2 2014 was Arrowstreet Capital, an estimated $70.5M added.
- The largest Novo Nordisk seller in Q2 2014 was Macquarie Group, an estimated $359M sold.
Based on aggregated 13F filings for Q2 2014.